HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Latin America and the Caribbean  /  BOL

Bolivia

Bolivia's Ministry of Health and Sports (MSyD, Ministerio de Salud y Deportes) publishes an epidemiology yearbook. Our project reads the notified HIV cases for the nine departments and nationally in 2016 from the 2016 yearbook, counting the cases notified with HIV and the cases notified in the AIDS phase together. The 2016 yearbook enters the panel only where the nine departments sum exactly to the national total in every column, and where the cases with HIV and the cases in the AIDS phase add to the printed total in every row.

40,000
People living with HIV, 2025
WHO Global Health Observatory
51.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$83k
United States HIV disbursements, 2026
ForeignAssistance.gov
$4.1m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$5m$10m200220052008201120142017202020232026$4.1m$85k$3.5m$83k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $259k — — —
2003 $1.0m $550k — $468k
2004 $3.5m $699k $2.1m $731k
2005 $714k $283k — $289k
2006 $5.2m $1.0m $2.7m $818k
2007 $4.1m $481k $1.8m $670k
2008 $6.0m $1.3m $3.5m $1.8m
2009 $7.3m $934k $4.8m $149k
2010 $5.5m $747k $3.9m $703k
2011 $6.9m $502k $4.5m $629k
2012 $2.0m $73k $1.0m $101k
2013 $9.4m $8k $8.2m —
2014 $3.0m $85k $1.8m $89k
2015 $5.4m — $5.0m $27
2016 $4.2m — $3.8m —
2017 $2.0m — $1.7m —
2018 $5.2m — $4.5m —
2019 $2.1m — $1.8m —
2020 $3.4m — $3.0m —
2021 $3.9m — $3.6m —
2022 $3.8m — $3.4m —
2023 $5.7m — $5.4m —
2024 $4.1m — $3.5m —
2025 — — — $615k
2026 — — — $83k

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
020k40k20002003200620092012201520182021202433,00019,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 15,000 12,000 19,000 —
2001 16,000 13,000 20,000 —
2002 17,000 14,000 21,000 —
2003 17,000 14,000 21,000 —
2004 18,000 14,000 22,000 —
2005 18,000 15,000 23,000 —
2006 19,000 15,000 23,000 —
2007 19,000 16,000 24,000 —
2008 20,000 16,000 25,000 —
2009 20,000 17,000 25,000 —
2010 21,000 17,000 26,000 1,300
2011 21,000 18,000 26,000 1,300
2012 22,000 18,000 27,000 2,300
2013 23,000 19,000 27,000 3,000
2014 23,000 19,000 28,000 3,800
2015 24,000 20,000 29,000 5,400
2016 25,000 21,000 30,000 6,600
2017 25,000 22,000 31,000 8,200
2018 26,000 22,000 32,000 10,000
2019 27,000 23,000 33,000 12,000
2020 28,000 24,000 34,000 13,000
2021 29,000 25,000 35,000 15,000
2022 30,000 26,000 36,000 15,000
2023 31,000 27,000 37,000 18,000
2024 33,000 28,000 39,000 19,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%20%40%60%2010201220142016201820202022202460.0%51.0%
  • On treatment
  • Virally suppressed
YearOn treatmentVirally suppressed
2010 6.0% —
2011 6.0% —
2012 11.0% —
2013 13.0% —
2014 16.0% —
2015 23.0% —
2016 27.0% 19.0%
2017 32.0% 22.0%
2018 38.0% 29.0%
2019 43.0% 33.0%
2020 46.0% 36.0%
2021 50.0% 42.0%
2022 51.0% 43.0%
2023 57.0% 46.0%
2024 60.0% 51.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Bolivia

2,956 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 750 27 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 248 12 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 147 16 2000–2025 extranet.who.int 2026-10-16
PAHO Core Indicators Programme record 93 1 1995–2025 opendata.paho.org 2026-10-13
Demographic and Health Surveys Survey 89 3 2003–2008 api.dhsprogram.com 2026-10-16
IATI, through d-portal Expenditure account 59 3 2000–2026 d-portal.org 2026-10-12
OECD Creditor Reporting System Expenditure account 55 3 2002–2024 sdmx.oecd.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
ForeignAssistance.gov Expenditure account 31 4 2003–2026 foreignassistance.gov 2026-10-29
Global Fund Data Service Programme record 29 4 2017–2025 fetch.theglobalfund.org 2026-10-12
Bolivia Ministry of Health and Sports epidemiology yearbook 2016 Programme record 10 1 2016 minsalud.gob.bo 2026-10-13
WHO HIV testing services dashboard Programme record 10 2 2022–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12
PAHO Interactive HIV Data Dashboard Programme record 4 1 2021–2023 paho.org 2026-10-14

Indicators held

59 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $0 (2024)
Budget required for collaborative TB/HIV activities Financing USD 6 2018–2025 WHO Global Tuberculosis Programme $11k (2025)
Country-reported HIV expenditure, all sources Financing USD 1 2012 UNAIDS AIDSinfo $11.8m (2012)
Domestic funding received by the national TB programme Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $1.6m (2024)
Expected Global Fund funding for the national TB programme Financing USD 7 2018–2025 WHO Global Tuberculosis Programme $1.1m (2025)
Expected USAID funding for the national TB programme Financing USD 7 2018–2025 WHO Global Tuberculosis Programme $0 (2025)
Expected domestic funding for the national TB programme Financing USD 7 2018–2025 WHO Global Tuberculosis Programme $1.7m (2025)
Expected funding for collaborative TB/HIV activities Financing USD 7 2018–2025 WHO Global Tuberculosis Programme $11k (2025)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $4.1m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 26 2000–2025 IATI, through d-portal $361k (2025)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 12 2013–2026 IATI, through d-portal $0 (2026)
External HIV financing from the United States (ODA) Financing USD 26 2003–2026 ForeignAssistance.gov, OECD Creditor Reporting System $83k (2026)
Funding received for collaborative TB/HIV activities Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $0 (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 8,672,371 (2026)
Global Fund HIV disbursements to the country Financing USD 41 2004–2025 IATI, through d-portal, OECD Creditor Reporting System $7.2m (2025)
Global Fund funding received by the national TB programme Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $1.4m (2024)
US HIV disbursements managed by USAID Financing USD 12 2003–2026 ForeignAssistance.gov $0 (2026)
US HIV disbursements managed by other US agencies Financing USD 4 2011–2015 ForeignAssistance.gov $27 (2015)
US HIV disbursements managed by the State Department Financing USD 1 2026 ForeignAssistance.gov $83k (2026)
USAID funding received by the national TB programme Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $0 (2024)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 19 2016–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 43.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 70 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 51.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 4 2024–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 83.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 15 2004–2024 UNAIDS AIDSinfo 40.3% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 2 2015–2021 UNAIDS AIDSinfo 10.0% (2021)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 1 2023 UNAIDS AIDSinfo 54.8% (2023)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 10 2016–2025 WHO Global Health Observatory 86.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 14 2022–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 0.5% (2024)
HIV tests performed with the result returned to the person Treatment cascade count 16 2022–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 658,621 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 2 2010–2022 UNAIDS AIDSinfo 30.0% (2022)
HIV-positive TB patients started or continued on ART Treatment cascade count 5 2015–2024 WHO Global Tuberculosis Programme 304 (2024)
Key-population people tested for HIV (count over the period) Treatment cascade count 9 2023–2025 Global Fund Data Service By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 1 2024 UNAIDS AIDSinfo 31.0% (2024)
Notified HIV cases, national case surveillance Treatment cascade count 103 1995–2025 Bolivia Ministry of Health and Sports epidemiology yearbook 2016, PAHO Core Indicators 3,576 (2025)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 76 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory 20,366 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 30 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 59.0% (2025)
People newly enrolled on ART during the year Treatment cascade count 3 2015–2023 WHO Global Tuberculosis Programme 3,269 (2023)
People on ART on a dolutegravir-based regimen Treatment cascade percent 4 2021–2023 PAHO Interactive HIV Data Dashboard By population group, sex or age only, to 2023
People tested for HIV in the last 12 months who received the result (household survey) Treatment cascade percent 19 2003–2008 Demographic and Health Surveys By population group, sex or age only, to 2008
Pregnant women tested for HIV in antenatal care Treatment cascade percent 9 2015–2024 UNAIDS AIDSinfo 96.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 463 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 467 (2024)
TB patients with an HIV test result recorded Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 8,747 (2024)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 1,000 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 250 (2024)
HIV prevalence among a key population Epidemic estimates percent 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 0.4% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 750 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 2,400 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 40,000 (2025)
Condom use at last higher-risk sex (household survey) Prevention and outreach percent 28 2003–2008 Demographic and Health Surveys By population group, sex or age only, to 2008
Key-population members reached by prevention programmes Prevention and outreach percent 2 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Key-population people reached by outreach (count over the period) Prevention and outreach count 9 2023–2025 Global Fund Data Service By population group, sex or age only, to 2025
Male condoms distributed in a year Prevention and outreach count 1 2022 UNAIDS AIDSinfo 3,800,000 (2022)
People with comprehensive correct knowledge of HIV (household survey) Prevention and outreach percent 42 2003–2008 Demographic and Health Surveys By population group, sex or age only, to 2008
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 780 (2025)
Estimated size of a key population Population denominators count 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 12,581,843 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 20.2% (2025)

Every row shown on the Bolivia page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.